Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents (Q36271731)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1 reference

Europe PubMed Central

Testosterone replacement therapy for male hypogonadism: part III. Pharmacologic and clinical profiles, monitoring, safety issues, and potential future agents (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Seftel A

1

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

publication date

29 September 2005

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

International Journal of Impotence Research

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

2-24

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

Summary of the recommendations on sexual dysfunctions in men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Effect of testosterone supplementation on sexual function in hypogonadal men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Evaluation of the pharmacokinetic profiles of the new testosterone topical gel formulation, Testim, compared to AndroGel

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Restorative increases in serum testosterone levels are significantly correlated to improvements in sexual functioning

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

AA2500 testosterone gel normalizes androgen levels in aging males with improvements in body composition and sexual function

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Erectile dysfunction and quality of life in type 2 diabetic patients: a serious problem too often overlooked

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Do impotent men with diabetes have more severe erectile dysfunction and worse quality of life than the general population of impotent patients? Results from the Exploratory Comprehensive Evaluation of Erectile Dysfunction (ExCEED) database

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Risk factors in predicting a poor response to sildenafil citrate in elderly men with erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Does sildenafil combined with testosterone gel improve erectile dysfunction in hypogonadal men in whom testosterone supplement therapy alone failed?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Safety and efficacy of testosterone gel 1% augmentation in depressed men with partial response to antidepressant therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Interpersonal testosterone transfer after topical application of a newly developed testosterone gel preparation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Pharmacokinetics of testosterone in hypogonadal men after transdermal delivery: influence of dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Long‐term efficacy and safety of a permeation‐enhanced testosterone transdermal system in hypogonadal men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Patient satisfaction with testosterone supplementation for the treatment of erectile dysfunction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Experience with transdermal testosterone replacement therapy for hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Short-term pharmacokinetic comparison of a novel testosterone buccal system and a testosterone gel in testosterone deficient men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

A comparison of a novel testosterone bioadhesive buccal system, striant, with a testosterone adhesive patch in hypogonadal males

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Androgen replacement with oral testosterone undecanoate in hypogonadal men: a double blind controlled study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Studies of 3,4-benzpyrene, 3-methylcholanthrene, chlordane, and methyltestosterone as stimulators of hepatic microsomal enzyme systems in the rat.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Multiple hepatic adenomas and a hepatocellular carcinoma in a man on oral methyl testosterone for eleven years

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Testosterone replacement: when is there a role?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Repeated intramuscular injections of testosterone undecanoate for substitution therapy in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Effects of Androgen on Sexual Behavior in Hypogonadal Men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Intramuscular injection of testosterone undecanoate for the treatment of male hypogonadism: phase I studies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

An analysis of testosterone implants for androgen replacement therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

A randomised controlled clinical trial of antibiotic impregnation of testosterone pellet implants to reduce extrusion rate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Risks of testosterone-replacement therapy and recommendations for monitoring

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: a review of the literature

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Managing the Risks of Prostate Disease During Testosterone Replacement Therapy in Older Men: Recommendations for a Standardized Monitoring Plan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Hypogonadism in elderly men--what to do until the evidence comes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Women's Health Initiative results: a glass more empty than full

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Issues to debate on the Women's Health Initiative (WHI) study. Hormone replacement therapy: an epidemiological dilemma?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Effect of exogenous testosterone replacement on prostate-specific antigen and prostate-specific membrane antigen levels in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Key structural features of nonsteroidal ligands for binding and activation of the androgen receptor.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Pharmacodynamics of selective androgen receptor modulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Antiandrogens: selective androgen receptor modulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Selective androgen receptor modulators (SARMs): a novel approach to androgen therapy for the new millennium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Dihydrotestosterone: a rationale for its use as a non-aromatizable androgen replacement therapeutic agent

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Differential effects on bone of estrogen receptor alpha and androgen receptor activation in orchidectomized adult male mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

The role of dihydrotestosterone in benign prostatic hyperplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Partitioning of 5alpha-dihydrotestosterone and 5alpha-androstane-3alpha, 17beta-diol activated pathways for stimulating human prostate cancer LNCaP cell proliferation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Expression of the disintegrin metalloprotease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I, and epidermal growth factor in the prostate cancer cell model LNCaP.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Design, synthesis, and biological characterization of metabolically stable selective androgen receptor modulators

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

New nonsteroidal androgen receptor modulators based on 4-(trifluoromethyl)-2(1H)-pyrrolidino[3,2-g] quinolinone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Bone Anabolic Effects of S-40503, a Novel Nonsteroidal Selective Androgen Receptor Modulator (SARM), in Rat Models of Osteoporosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Androgens, behaviour and nocturnal erection in hypogonadal men: the effects of varying the replacement dose

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

21 January 2018

Bioequivalence assessment of a single 5 mg/day testosterone transdermal system versus two 2.5 mg/day systems in hypogonadal men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Testosterone therapy for low sexual interest and erectile dysfunction in men: a controlled study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral androgens in the treatment of hypogonadal impotent men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Liver damage from long-term methyltestosterone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized clinical trial of testosterone replacement therapy in hypogonadal men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of testosterone replacement on sexual behavior in hypogonadal men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics and pharmacodynamics of testosterone pellets in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Extrusion of testosterone pellets: a randomized controlled clinical study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Prostate volume in testosterone-treated and untreated hypogonadal men in comparison to age-matched normal controls

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes of Long-Term Testosterone Replacement in Older Hypogonadal Males: A Retrospective Analysis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Pharmacokinetics of 7 alpha-methyl-19-nortestosterone (MENT) delivery using subdermal implants in healthy men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Initial trial of slow-release testosterone microspheres in hypogonadal men

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJIR.3901366

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.IJIR.3901366

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36271731&oldid=2198516674"